Back
Saul Centers 10K Form
Buy
54
BFS
Saul Centers
Last Price:
38.72
Seasonality Move:
3.18%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-02 | 10Q | BFS/Saul Centers Quarterly |
| 2024-02-29 | 10K | BFS/Saul Centers Annual |
| 2023-11-02 | 10Q | BFS/Saul Centers Quarterly |
| 2023-08-03 | 10Q | BFS/Saul Centers Quarterly |
| 2023-05-04 | 10Q | BFS/Saul Centers Quarterly |
| 2023-03-02 | 10K | BFS/Saul Centers Annual |
Receive BFS News And Ratings
See the #1 stock for the next 7 days that we like better than BFS
BFS Financial Statistics
Sales & Book Value
| Annual Sales: | $257.21M |
|---|---|
| Cash Flow: | $32.13M |
| Price / Cash Flow: | 9.9 |
| Annual Sales: | $6.62 |
| Price / Book: | 5.88 |
Profitability
| EPS (TTM): | 1.79000 |
|---|---|
| Net Income (TTM): | $54.1M |
| Gross Margin: | $190.07M |
| Return on Equity: | 10.58% |
| Return on Assets: | 2.72% |
Saul Centers Earnings Forecast
Key Saul Centers Financial Ratios
- The Gross Profit Margin over the past 17 years for BFS is 73.90%.
- The Selling, General & Administrative Expenses for BFS have been equal to 9.12% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 89.58% of Operating Income.
- The Net Earning history of BFS is 20.49% of Total Revenues.
- Per Share Earnings over the last 31 years have been positive in 16 years.
Saul Centers Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Retail REITs |
| Sector: | Real Estate |
| Current Symbol: | BFS |
| CUSIP: | 804395 |
| Website: | saulcenters.com |
Debt
| Debt-to-Equity Ratio: | 4.17 |
|---|---|
| Current Ratio: | 0.18 |
| Quick Ratio: | 0.18 |
Price-to-Earnings
| Trailing P/E Ratio: | 22.62 |
|---|---|
| Forward P/E Ratio: | 28.78 |
BFS Technical Analysis vs Fundamental Analysis
Buy
54
Saul Centers (BFS)
is a Buy
Is Saul Centers a Buy or a Sell?
-
Saul Centers stock is rated a Buy
The current Saul Centers [BFS] share price is $38.75. The Score for BFS is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.